Inclusion Criteria

DISEASE CHARACTERISTICS:

- Diagnosis of potentially resectable colorectal liver metastases that meets one of the
following criteria:

- Metachronous metastases after complete resection of primary tumor without gross
or microscopic evidence of residual disease

- Synchronous metastases after complete resection of primary tumor more than 1
month before study

- Synchronous metastases with sufficient evidence (i.e., CAT scan or diagnostic
laparoscopy) that both the primary tumor and liver metastases can be completely
resected during the same procedure and resection of primary may be delayed 3-4
months

PATIENT CHARACTERISTICS:

Age:

- 18 to 80

Performance status:

- WHO 0-2

- Karnofsky 60-100%

Life expectancy:

- Not specified

Hematopoietic:

- Absolute neutrophil count greater than 1,500/mm^3

- Platelet count greater than 100,000/mm^3

Hepatic:

- No hepatic insufficiency

Renal:

- Creatinine less than 2 times upper limit of normal

Cardiovascular:

- No uncontrolled congestive heart failure or angina pectoris

- No hypertension or arrhythmia

Other:

- No other malignancy within the past 10 years except adequately treated carcinoma in
situ of the cervix or nonmelanoma skin cancer

- No peripheral neuropathy greater than grade 1

- No prior significant neurologic or psychiatric disorders

- No active infection

- Not pregnant or nursing

- Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- No concurrent biologic therapy

Chemotherapy:

- No prior chemotherapy for advanced disease

- Prior adjuvant chemotherapy for primary cancer allowed unless included oxaliplatin

- No other concurrent chemotherapy

Endocrine therapy:

- No concurrent anticancer endocrine therapy

Radiotherapy:

- No concurrent radiotherapy

Surgery:

- See Disease Characteristics

Other:

- At least 30 days since prior investigational drugs

- No concurrent investigational drugs